Dung Le

Associate Professor

20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Dung Le is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Immunotherapy Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Microsatellite Instability Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (Journal for Immuno Therapy of Cancer (2019) 7 (40) DOI: 10.1186/s40425-018-0492-x)

Smith, K., Llosa, N., Cottrell, T. R., Siegel, N., Fan, H., Suri, P., Chan, H. Y., Guo, H., Oke, T., Awan, A. H., Verde, F., Danilova, L. V., Anagnostou, V., Tam, A. J., Luber, B. S., Bartlett, B. R., Aulakh, L. K., Sidhom, J. W., Zhu, Q., Sears, C. L. & 21 others, Cope, L., Sharfman, W., Thompson, E., Riemer, J., Marrone, K., Naidoo, J., Velculescu, V. E., Forde, P., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., Durham, J. N., Wang, H., Le, D., Justesen, S., Taube, J. M., Diaz, L. A., Brahmer, J., Pardoll, A. M., Anders, R. A. & Housseau, F., Mar 6 2019, In : Journal for immunotherapy of cancer. 7, 1, 7.

Research output: Contribution to journalComment/debate

Consultants
Oncogenes
T-Lymphocytes
Conflict of Interest
Organized Financing

Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer

Chau, I., Le, D. T., Ott, P. A., Korytowsky, B., Le, H., Le, T. K., Zhang, Y., Sanchez, T., Maglinte, G. A., Laurie, M., Abraham, P., Patel, D. & Shangguan, T., Jan 1 2019, (Accepted/In press) In : Gastric Cancer.

Research output: Contribution to journalArticle

Pragmatic Clinical Trials
Esophagogastric Junction
Stomach Neoplasms
Drug Therapy
Survival

Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response

Mandal, R., Samstein, R. M., Lee, K. W., Havel, J. J., Wang, H., Krishna, C., Sabio, E. Y., Makarov, V., Kuo, F., Blecua, P., Ramaswamy, A. T., Durham, J. N., Bartlett, B., Ma, X., Srivastava, R., Middha, S., Zehir, A., Hechtman, J. F., Morris, L. G., Weinhold, N. & 4 others, Riaz, N., Le, D., Diaz, L. A. & Chan, T. A., May 3 2019, In : Science (New York, N.Y.). 364, 6439, p. 485-491 7 p.

Research output: Contribution to journalArticle

Immunotherapy
Cell Death
Microsatellite Instability
Neoplasms
Tumor Burden

Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

Braaten, T. J., Brahmer, J., Forde, P., Le, D., Lipson, E., Naidoo, J., Schollenberger, M., Zheng, L., Bingham, C., Shah, A. & Cappelli, L., Jan 1 2019, (Accepted/In press) In : Annals of the rheumatic diseases.

Research output: Contribution to journalArticle

Synovitis
Immunotherapy
Autoimmune Diseases
Arthritis
Tumors

Immunopathologic stratification of colorectal cancer for checkpoint blockade immunotherapy

Llosa, N., Luber, B., Siegel, N., Awan, A. H., Oke, T., Zhu, Q., Bartlett, B. R., Aulakh, L. K., Thompson, E., Jaffee, E., Durham, J. N., Sears, C. L., Le, D., Diaz, L. A., Pardoll, A. M., Wang, H., Housseau, F. & Anders, R. A., Jan 1 2019, In : Cancer Immunology Research. 7, 10, p. 1574-1579 6 p.

Research output: Contribution to journalArticle

Immunotherapy
Colorectal Neoplasms
Mucins
Microsatellite Instability
Neoplasms